| 靶点: |
SCD1 |
| 体内研究: |
SCD1 inhibitor-3 (compound 17a) (5 mg/kg; p.o.; 4 hours) reduces the plasma C16:1/C16:0 triglycerides desaturation index by 54 %. SCD1 inhibitor-3 (2~10 mg/kg; p.o.; 4 hours) makes a dose-responsive reduction of plasma triglycerides desaturation index. |
| 参考文献: |
1. Sun S, et al. Discovery of triazolone derivatives as novel, potent stearoyl-CoA desaturase-1 (SCD1) inhibitors. Bioorg Med Chem. 2015;23(3):455-465. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.542 ml |
12.711 ml |
25.421 ml |
| 5 mM |
0.508 ml |
2.542 ml |
5.084 ml |
| 10 mM |
0.254 ml |
1.271 ml |
2.542 ml |
| 50 mM |
0.051 ml |
0.254 ml |
0.508 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |